Main > PNEUMOLOGY > Asthma > Treatment > Steroids > Mometasone Furoate. > NonGeneric Mometasone Furoate > Patent. > Claims > Claim 1: CorticoSteroid-Responsive > Disease of the Lower Airway Passage > Treat. Method: Adm. as Initial or > Maintenance Therapy to the Surfaces > of Passages > Once Daily Non- > Systemically BioAvailable Amount of > Aerosolized Particles of Mometasone > Furoate. Claim 2: Disease: > Allergic or Inflammatory Disease. > Claim 3: Disease: Asthma. Claims > 10,11: Daily Amount=10-2000 & > 50-1000 micrograms resp. Claims

---

50-1000 micrograms resp. Claims's subsections
12,13: Adm. Once Daily. Claim 14:

50-1000 micrograms resp. Claims's products
This section has no products